Patents Assigned to BEIJING IMMUNOCHINA PHARMACEUTICALS CO., LTD.
  • Publication number: 20230346937
    Abstract: The present invention relates to the optimization of a chimeric antigen receptor, in particular, the modification am intracellular co-stimulatory domain.
    Type: Application
    Filed: February 9, 2021
    Publication date: November 2, 2023
    Applicant: BEIJING IMMUNOCHINA PHARMACEUTICALS CO., LTD.
    Inventors: Xinan LU, Ting HE, Feifei QI, Yanping DING, Fuyin XIONG, Mengmeng LIANG
  • Publication number: 20230340063
    Abstract: The present invention relates to the optimization of a chimeric antigen receptor, in particular, the modification of an intracellular signaling domain.
    Type: Application
    Filed: February 9, 2021
    Publication date: October 26, 2023
    Applicant: BEIJING IMMUNOCHINA PHARMACEUTICALS CO., LTD.
    Inventors: Feifei QI, Ting HE, Xinan LU, Yanping DING, Fuyin XIONG, Mengmeng LIANG